BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1326813	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(CC1)Oc1ccccc1 |r,w:7.8|	InChI=1S/C28H35N5O6/c1-17(2)25(23-14-24(37-3)31-39-23)28(36)33-16-18(34)13-22(33)26-29-15-21(30-26)27(35)32-11-9-20(10-12-32)38-19-7-5-4-6-8-19/h4-8,14-15,17-18,20,22,25,34H,9-13,16H2,1-3H3,(H,29,30)	TZBPBIMNKGQXKH-UHFFFAOYSA-N	621974	US20230312542, Example 1	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621974	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621974&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873536	485229116							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326814	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc([nH]1)-c1cccc(c1)-c1scnc1C)C(C)(C)C |r|	InChI=1S/C25H31N5O3S/c1-14-21(34-13-27-14)17-8-6-7-16(9-17)19-11-26-23(29-19)20-10-18(32)12-30(20)24(33)22(25(3,4)5)28-15(2)31/h6-9,11,13,18,20,22,32H,10,12H2,1-5H3,(H,26,29)(H,28,31)	CZGXUBOQUPSMHG-UHFFFAOYSA-N	621975	US20230312542, Example 6	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621975	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621975&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873399	485229117							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326815	CN(Cc1ccccc1Cl)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H32ClN5O4/c1-14(31)27-20(24(2,3)4)23(34)30-13-16(32)10-19(30)21-26-11-18(28-21)22(33)29(5)12-15-8-6-7-9-17(15)25/h6-9,11,16,19-20,32H,10,12-13H2,1-5H3,(H,26,28)(H,27,31)	OPHTZZOCAPNJIT-UHFFFAOYSA-N	621976	US20230312542, Example 14	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621976	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621976&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873362	485229118							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326816	CN(Cc1cccc(Cl)c1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H32ClN5O4/c1-14(31)27-20(24(2,3)4)23(34)30-13-17(32)10-19(30)21-26-11-18(28-21)22(33)29(5)12-15-7-6-8-16(25)9-15/h6-9,11,17,19-20,32H,10,12-13H2,1-5H3,(H,26,28)(H,27,31)	WKSLRYDKFDSAST-UHFFFAOYSA-N	621977	US20230312542, Example 15	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621977	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621977&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873398	485229119							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326817	CN(Cc1ccc(Cl)cc1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H32ClN5O4/c1-14(31)27-20(24(2,3)4)23(34)30-13-17(32)10-19(30)21-26-11-18(28-21)22(33)29(5)12-15-6-8-16(25)9-7-15/h6-9,11,17,19-20,32H,10,12-13H2,1-5H3,(H,26,28)(H,27,31)	VLVGYBCJBCMXTF-UHFFFAOYSA-N	621978	US20230312542, Example 16	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621978	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621978&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873321	485229120							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326818	CN(Cc1ccccc1F)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H32FN5O4/c1-14(31)27-20(24(2,3)4)23(34)30-13-16(32)10-19(30)21-26-11-18(28-21)22(33)29(5)12-15-8-6-7-9-17(15)25/h6-9,11,16,19-20,32H,10,12-13H2,1-5H3,(H,26,28)(H,27,31)	RBRBALPLQJUNLC-UHFFFAOYSA-N	621979	US20230312542, Example 17	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621979	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621979&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873422	485229121							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326819	CN(Cc1cccc(F)c1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H32FN5O4/c1-14(31)27-20(24(2,3)4)23(34)30-13-17(32)10-19(30)21-26-11-18(28-21)22(33)29(5)12-15-7-6-8-16(25)9-15/h6-9,11,17,19-20,32H,10,12-13H2,1-5H3,(H,26,28)(H,27,31)	OIEPCEAXQUKPLW-UHFFFAOYSA-N	621980	US20230312542, Example 18	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621980	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621980&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873406	485229122							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326820	CN(Cc1ccc(F)cc1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H32FN5O4/c1-14(31)27-20(24(2,3)4)23(34)30-13-17(32)10-19(30)21-26-11-18(28-21)22(33)29(5)12-15-6-8-16(25)9-7-15/h6-9,11,17,19-20,32H,10,12-13H2,1-5H3,(H,26,28)(H,27,31)	HMGFLPLHUGCOMH-UHFFFAOYSA-N	621981	US20230312542, Example 19	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621981	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621981&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873454	485229123							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326821	CN(Cc1ccccc1C(F)(F)F)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C25H32F3N5O4/c1-14(34)30-20(24(2,3)4)23(37)33-13-16(35)10-19(33)21-29-11-18(31-21)22(36)32(5)12-15-8-6-7-9-17(15)25(26,27)28/h6-9,11,16,19-20,35H,10,12-13H2,1-5H3,(H,29,31)(H,30,34)	IPRATMSLXQTJCC-UHFFFAOYSA-N	621982	US20230312542, Example 20	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621982	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621982&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873343	485229124							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326822	CN(Cc1cccc(c1)C(F)(F)F)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C25H32F3N5O4/c1-14(34)30-20(24(2,3)4)23(37)33-13-17(35)10-19(33)21-29-11-18(31-21)22(36)32(5)12-15-7-6-8-16(9-15)25(26,27)28/h6-9,11,17,19-20,35H,10,12-13H2,1-5H3,(H,29,31)(H,30,34)	QPSKKWONIYKSRA-UHFFFAOYSA-N	621983	US20230312542, Example 21	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621983	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621983&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873275	485229125							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326823	CN(Cc1ccc(cc1)C(F)(F)F)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C25H32F3N5O4/c1-14(34)30-20(24(2,3)4)23(37)33-13-17(35)10-19(33)21-29-11-18(31-21)22(36)32(5)12-15-6-8-16(9-7-15)25(26,27)28/h6-9,11,17,19-20,35H,10,12-13H2,1-5H3,(H,29,31)(H,30,34)	SFQJRNUACYVVPM-UHFFFAOYSA-N	621984	US20230312542, Example 22	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621984	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621984&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873500	485229126							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326824	COc1ccccc1CN(C)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C25H35N5O5/c1-15(31)27-21(25(2,3)4)24(34)30-14-17(32)11-19(30)22-26-12-18(28-22)23(33)29(5)13-16-9-7-8-10-20(16)35-6/h7-10,12,17,19,21,32H,11,13-14H2,1-6H3,(H,26,28)(H,27,31)	LQDCCDIGHSQZBO-UHFFFAOYSA-N	621985	US20230312542, Example 23	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621985	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621985&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873355	485229127							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326825	COc1cccc(CN(C)C(=O)c2c[nH]c(n2)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(C)=O)C(C)(C)C)c1 |r|	InChI=1S/C25H35N5O5/c1-15(31)27-21(25(2,3)4)24(34)30-14-17(32)11-20(30)22-26-12-19(28-22)23(33)29(5)13-16-8-7-9-18(10-16)35-6/h7-10,12,17,20-21,32H,11,13-14H2,1-6H3,(H,26,28)(H,27,31)	LOAOTIITMIIILS-UHFFFAOYSA-N	621986	US20230312542, Example 24	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621986	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621986&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873386	485229128							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326826	COc1ccc(CN(C)C(=O)c2c[nH]c(n2)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(C)=O)C(C)(C)C)cc1 |r|	InChI=1S/C25H35N5O5/c1-15(31)27-21(25(2,3)4)24(34)30-14-17(32)11-20(30)22-26-12-19(28-22)23(33)29(5)13-16-7-9-18(35-6)10-8-16/h7-10,12,17,20-21,32H,11,13-14H2,1-6H3,(H,26,28)(H,27,31)	WSBNCONWUJVKAS-UHFFFAOYSA-N	621987	US20230312542, Example 25	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621987	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621987&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873307	485229129							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326827	CN(Cc1cccc(c1)-c1scnc1C)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C28H36N6O4S/c1-16-23(39-15-30-16)19-9-7-8-18(10-19)13-33(6)26(37)21-12-29-25(32-21)22-11-20(36)14-34(22)27(38)24(28(3,4)5)31-17(2)35/h7-10,12,15,20,22,24,36H,11,13-14H2,1-6H3,(H,29,32)(H,31,35)	LBUOYWKXANEWPH-UHFFFAOYSA-N	621988	US20230312542, Example 29	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621988	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621988&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873441	485229130							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326828	CN(Cc1ccc2ccccc2c1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C28H35N5O4/c1-17(34)30-24(28(2,3)4)27(37)33-16-21(35)13-23(33)25-29-14-22(31-25)26(36)32(5)15-18-10-11-19-8-6-7-9-20(19)12-18/h6-12,14,21,23-24,35H,13,15-16H2,1-5H3,(H,29,31)(H,30,34)	ZQWQFUVLZAYOLM-UHFFFAOYSA-N	621989	US20230312542, Example 30	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621989	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621989&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873280	485229131							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326829	CN(Cc1cccc2ccccc12)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C28H35N5O4/c1-17(34)30-24(28(2,3)4)27(37)33-16-20(35)13-23(33)25-29-14-22(31-25)26(36)32(5)15-19-11-8-10-18-9-6-7-12-21(18)19/h6-12,14,20,23-24,35H,13,15-16H2,1-5H3,(H,29,31)(H,30,34)	NUJZVECZTRDXGD-UHFFFAOYSA-N	621990	US20230312542, Example 31	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621990	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621990&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873426	485229132							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326830	CN(Cc1ccc(cc1)-c1scnc1C)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C28H36N6O4S/c1-16-23(39-15-30-16)19-9-7-18(8-10-19)13-33(6)26(37)21-12-29-25(32-21)22-11-20(36)14-34(22)27(38)24(28(3,4)5)31-17(2)35/h7-10,12,15,20,22,24,36H,11,13-14H2,1-6H3,(H,29,32)(H,31,35)	FWEJPWJHGQUJLN-UHFFFAOYSA-N	621991	US20230312542, Example 35	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621991	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621991&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873205	485229133							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326831	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(Cc1ccc(cc1)-c1scnc1C)CC(F)(F)F |r,w:7.8|	InChI=1S/C30H33F3N6O5S/c1-16(2)25(23-10-24(43-4)37-44-23)29(42)39-13-20(40)9-22(39)27-34-11-21(36-27)28(41)38(14-30(31,32)33)12-18-5-7-19(8-6-18)26-17(3)35-15-45-26/h5-8,10-11,15-16,20,22,25,40H,9,12-14H2,1-4H3,(H,34,36)	YTSQNILJOGYCRL-UHFFFAOYSA-N	621992	US20230312542, Example 40	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621992	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621992&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873314	485229134							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326832	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc([nH]1)-c1cccc(c1)-c1scnc1C |r,w:7.8|	InChI=1S/C26H29N5O4S/c1-14(2)23(21-10-22(34-4)30-35-21)26(33)31-12-18(32)9-20(31)25-27-11-19(29-25)16-6-5-7-17(8-16)24-15(3)28-13-36-24/h5-8,10-11,13-14,18,20,23,32H,9,12H2,1-4H3,(H,27,29)	UAJFHQYLIGTBHQ-UHFFFAOYSA-N	621993	US20230312542, Example 44	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621993	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621993&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873331	485229135							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326833	CN(Cc1ccccn1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C23H32N6O4/c1-14(30)26-19(23(2,3)4)22(33)29-13-16(31)10-18(29)20-25-11-17(27-20)21(32)28(5)12-15-8-6-7-9-24-15/h6-9,11,16,18-19,31H,10,12-13H2,1-5H3,(H,25,27)(H,26,30)	QDGWHHIKNDBRGA-UHFFFAOYSA-N	621994	US20230312542, Example 48	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621994	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621994&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873247	485229136							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326834	CN(Cc1ccncc1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C23H32N6O4/c1-14(30)26-19(23(2,3)4)22(33)29-13-16(31)10-18(29)20-25-11-17(27-20)21(32)28(5)12-15-6-8-24-9-7-15/h6-9,11,16,18-19,31H,10,12-13H2,1-5H3,(H,25,27)(H,26,30)	MHNYMFABAZAOPD-UHFFFAOYSA-N	621995	US20230312542, Example 49	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621995	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621995&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873523	485229137							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326835	CN(Cc1ccccc1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C24H33N5O4/c1-15(30)26-20(24(2,3)4)23(33)29-14-17(31)11-19(29)21-25-12-18(27-21)22(32)28(5)13-16-9-7-6-8-10-16/h6-10,12,17,19-20,31H,11,13-14H2,1-5H3,(H,25,27)(H,26,30)	UVFZXPWWKAKALW-UHFFFAOYSA-N	621996	US20230312542, Example 51	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621996	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621996&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873353	485229138							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326836	CN(Cc1cccnc1)C(=O)c1c[nH]c(n1)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(C)=O)C(C)(C)C |r|	InChI=1S/C23H32N6O4/c1-14(30)26-19(23(2,3)4)22(33)29-13-16(31)9-18(29)20-25-11-17(27-20)21(32)28(5)12-15-7-6-8-24-10-15/h6-8,10-11,16,18-19,31H,9,12-13H2,1-5H3,(H,25,27)(H,26,30)	OMAMEWAIYLUERW-UHFFFAOYSA-N	621997	US20230312542, Example 53	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621997	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621997&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873392	485229139							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326837	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(C)Cc1ccc(cc1)-c1scnc1C |r,w:7.8|	InChI=1S/C29H34N6O5S/c1-16(2)25(23-11-24(39-5)33-40-23)29(38)35-14-20(36)10-22(35)27-30-12-21(32-27)28(37)34(4)13-18-6-8-19(9-7-18)26-17(3)31-15-41-26/h6-9,11-12,15-16,20,22,25,36H,10,13-14H2,1-5H3,(H,30,32)	SLDKKUWJUJYJSN-UHFFFAOYSA-N	621998	US20230312542, Example 54	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621998	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621998&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873430	485229140							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326838	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc([nH]1)-c1cccc(OC)c1 |r,w:7.8|	InChI=1S/C23H28N4O5/c1-13(2)21(19-10-20(31-4)26-32-19)23(29)27-12-15(28)9-18(27)22-24-11-17(25-22)14-6-5-7-16(8-14)30-3/h5-8,10-11,13,15,18,21,28H,9,12H2,1-4H3,(H,24,25)	PUJGWCFVWOMGJA-UHFFFAOYSA-N	621999	US20230312542, Example 61	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=621999	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=621999&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873403	485229141							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326839	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2ccc(OC)cc2)[nH]1 |r,w:7.8|	InChI=1S/C24H30N4O5/c1-14(2)22(20-11-21(32-4)27-33-20)24(30)28-13-17(29)10-19(28)23-25-12-16(26-23)9-15-5-7-18(31-3)8-6-15/h5-8,11-12,14,17,19,22,29H,9-10,13H2,1-4H3,(H,25,26)	ULWBHVHCQBTUAV-UHFFFAOYSA-N	622000	US20230312542, Example 62	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622000	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622000&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873427	485229142							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326840	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2cccc(OC)c2)[nH]1 |r,w:7.8|	InChI=1S/C24H30N4O5/c1-14(2)22(20-11-21(32-4)27-33-20)24(30)28-13-17(29)10-19(28)23-25-12-16(26-23)8-15-6-5-7-18(9-15)31-3/h5-7,9,11-12,14,17,19,22,29H,8,10,13H2,1-4H3,(H,25,26)	APNZDSGNTFAPHU-UHFFFAOYSA-N	622001	US20230312542, Example 63	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622001	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622001&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873505	485229143							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326841	CNC(=O)c1ccccc1-c1cnc([nH]1)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(OC)no1 |r,w:23.26|	InChI=1S/C24H29N5O5/c1-13(2)21(19-10-20(33-4)28-34-19)24(32)29-12-14(30)9-18(29)22-26-11-17(27-22)15-7-5-6-8-16(15)23(31)25-3/h5-8,10-11,13-14,18,21,30H,9,12H2,1-4H3,(H,25,31)(H,26,27)	JJEVVZFOHYFDMV-UHFFFAOYSA-N	622002	US20230312542, Example 64	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622002	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622002&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873407	485229144							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326842	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nccn1Cc1cccc(Oc2ccccc2)c1 |r,w:7.8|	InChI=1S/C29H32N4O5/c1-19(2)27(25-16-26(36-3)31-38-25)29(35)33-18-21(34)15-24(33)28-30-12-13-32(28)17-20-8-7-11-23(14-20)37-22-9-5-4-6-10-22/h4-14,16,19,21,24,27,34H,15,17-18H2,1-3H3	MWBZQSLFMRWBCN-UHFFFAOYSA-N	622003	US20230312542, Example 65	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622003	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622003&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873288	485229145							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326843	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nccn1Cc1ccccc1OCc1ccccc1 |r,w:7.8|	InChI=1S/C30H34N4O5/c1-20(2)28(26-16-27(37-3)32-39-26)30(36)34-18-23(35)15-24(34)29-31-13-14-33(29)17-22-11-7-8-12-25(22)38-19-21-9-5-4-6-10-21/h4-14,16,20,23-24,28,35H,15,17-19H2,1-3H3	XURSXZSHGSDGBG-UHFFFAOYSA-N	622004	US20230312542, Example 66	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622004	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622004&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873436	485229146							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326844	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nccn1Cc1ccccc1Oc1ccccc1 |r,w:7.8|	InChI=1S/C29H32N4O5/c1-19(2)27(25-16-26(36-3)31-38-25)29(35)33-18-21(34)15-23(33)28-30-13-14-32(28)17-20-9-7-8-12-24(20)37-22-10-5-4-6-11-22/h4-14,16,19,21,23,27,34H,15,17-18H2,1-3H3	YXNOFIHSSGUPDW-UHFFFAOYSA-N	622005	US20230312542, Example 69	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622005	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622005&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873323	485229147							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326845	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c([nH]1)-c1ccc(OC)cc1)C(F)(F)F |r,w:7.8|	InChI=1S/C24H27F3N4O5/c1-12(2)19(17-10-18(35-4)30-36-17)23(33)31-11-14(32)9-16(31)22-28-20(21(29-22)24(25,26)27)13-5-7-15(34-3)8-6-13/h5-8,10,12,14,16,19,32H,9,11H2,1-4H3,(H,28,29)	IJTAXKXBKUDDDL-UHFFFAOYSA-N	622006	US20230312542, Example 74	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622006	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622006&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873447	485229148							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326846	CNC(=O)c1nc([nH]c1-c1ccc(OC)cc1)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(OC)no1 |r,w:25.28|	InChI=1S/C25H31N5O6/c1-13(2)20(18-11-19(35-5)29-36-18)25(33)30-12-15(31)10-17(30)23-27-21(22(28-23)24(32)26-3)14-6-8-16(34-4)9-7-14/h6-9,11,13,15,17,20,31H,10,12H2,1-5H3,(H,26,32)(H,27,28)	YUEYWAGYLYIOPW-UHFFFAOYSA-N	622007	US20230312542, Example 75	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622007	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622007&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873506	485229149							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326847	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c([nH]1)-c1cccc(OC)c1)-c1cccc(OC)c1 |r,w:7.8|	InChI=1S/C30H34N4O6/c1-17(2)26(24-15-25(39-5)33-40-24)30(36)34-16-20(35)14-23(34)29-31-27(18-8-6-10-21(12-18)37-3)28(32-29)19-9-7-11-22(13-19)38-4/h6-13,15,17,20,23,26,35H,14,16H2,1-5H3,(H,31,32)	DOSLLXITMFBIKE-UHFFFAOYSA-N	622008	US20230312542, Example 76	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622008	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622008&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873202	485229150							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326848	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc([nH]1)-c1ccc(OC)cc1 |r,w:7.8|	InChI=1S/C23H28N4O5/c1-13(2)21(19-10-20(31-4)26-32-19)23(29)27-12-15(28)9-18(27)22-24-11-17(25-22)14-5-7-16(30-3)8-6-14/h5-8,10-11,13,15,18,21,28H,9,12H2,1-4H3,(H,24,25)	ZNCVHNVJFYMBBV-UHFFFAOYSA-N	622009	US20230312542, Example 78	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622009	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622009&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873270	485229151							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326849	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2ccc(cc2)C(F)(F)F)[nH]1 |r,w:7.8|	InChI=1S/C24H27F3N4O4/c1-13(2)21(19-10-20(34-3)30-35-19)23(33)31-12-17(32)9-18(31)22-28-11-16(29-22)8-14-4-6-15(7-5-14)24(25,26)27/h4-7,10-11,13,17-18,21,32H,8-9,12H2,1-3H3,(H,28,29)	WXBYWUANSTXDSF-UHFFFAOYSA-N	622010	US20230312542, Example 79	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622010	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622010&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873203	485229152							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326850	CNC(=O)c1cccc(c1)-c1cnc([nH]1)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(OC)no1 |r,w:23.26|	InChI=1S/C24H29N5O5/c1-13(2)21(19-10-20(33-4)28-34-19)24(32)29-12-16(30)9-18(29)22-26-11-17(27-22)14-6-5-7-15(8-14)23(31)25-3/h5-8,10-11,13,16,18,21,30H,9,12H2,1-4H3,(H,25,31)(H,26,27)	JICNIMVCOFKHAA-UHFFFAOYSA-N	622011	US20230312542, Example 80	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622011	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622011&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873311	485229153							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326851	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2ccc(Br)cc2)[nH]1)C(C)(C)C |r|	InChI=1S/C22H29BrN4O3/c1-13(28)25-19(22(2,3)4)21(30)27-12-17(29)10-18(27)20-24-11-16(26-20)9-14-5-7-15(23)8-6-14/h5-8,11,17-19,29H,9-10,12H2,1-4H3,(H,24,26)(H,25,28)	YFDRYWBFEGJVTF-UHFFFAOYSA-N	622012	US20230312542, Example 81	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622012	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622012&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873223	485229154							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326852	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc([nH]1)-c1ccccc1C(F)(F)F)C(C)(C)C |r|	InChI=1S/C22H27F3N4O3/c1-12(30)27-18(21(2,3)4)20(32)29-11-13(31)9-17(29)19-26-10-16(28-19)14-7-5-6-8-15(14)22(23,24)25/h5-8,10,13,17-18,31H,9,11H2,1-4H3,(H,26,28)(H,27,30)	JFPGODRLGDSMBC-UHFFFAOYSA-N	622013	US20230312542, Example 84	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622013	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622013&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873435	485229155							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326853	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc([nH]1)-c1ccc(cc1)-c1scnc1C)C(C)(C)C |r|	InChI=1S/C25H31N5O3S/c1-14-21(34-13-27-14)17-8-6-16(7-9-17)19-11-26-23(29-19)20-10-18(32)12-30(20)24(33)22(25(3,4)5)28-15(2)31/h6-9,11,13,18,20,22,32H,10,12H2,1-5H3,(H,26,29)(H,28,31)	BPLKGRAJVBNHOW-UHFFFAOYSA-N	622014	US20230312542, Example 89	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622014	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622014&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873291	485229156							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326854	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2cccc(Br)c2)[nH]1)C(C)(C)C |r|	InChI=1S/C22H29BrN4O3/c1-13(28)25-19(22(2,3)4)21(30)27-12-17(29)10-18(27)20-24-11-16(26-20)9-14-6-5-7-15(23)8-14/h5-8,11,17-19,29H,9-10,12H2,1-4H3,(H,24,26)(H,25,28)	FUIAIGIDSCWUNV-UHFFFAOYSA-N	622015	US20230312542, Example 90	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622015	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622015&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873327	485229157							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326855	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2cccc(c2)-c2scnc2C)[nH]1)C(C)(C)C |r|	InChI=1S/C26H33N5O3S/c1-15-22(35-14-28-15)18-8-6-7-17(9-18)10-19-12-27-24(30-19)21-11-20(33)13-31(21)25(34)23(26(3,4)5)29-16(2)32/h6-9,12,14,20-21,23,33H,10-11,13H2,1-5H3,(H,27,30)(H,29,32)	KQMONOVAOLPQIA-UHFFFAOYSA-N	622016	US20230312542, Example 91	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622016	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622016&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873538	485229158							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326856	CC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1c1ncc(Cc2ccc(cc2)-c2scnc2C)[nH]1)C(C)(C)C |r|	InChI=1S/C26H33N5O3S/c1-15-22(35-14-28-15)18-8-6-17(7-9-18)10-19-12-27-24(30-19)21-11-20(33)13-31(21)25(34)23(26(3,4)5)29-16(2)32/h6-9,12,14,20-21,23,33H,10-11,13H2,1-5H3,(H,27,30)(H,29,32)	RTUBSSSFWCFHOD-UHFFFAOYSA-N	622017	US20230312542, Example 93	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622017	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622017&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873341	485229159							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326857	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nccn1CC(=O)Nc1ccccc1 |r,w:7.8|	InChI=1S/C24H29N5O5/c1-15(2)22(19-12-21(33-3)27-34-19)24(32)29-13-17(30)11-18(29)23-25-9-10-28(23)14-20(31)26-16-7-5-4-6-8-16/h4-10,12,15,17-18,22,30H,11,13-14H2,1-3H3,(H,26,31)	OFQVVQDDQCQXIN-UHFFFAOYSA-N	622018	US20230312542, Example 96	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622018	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622018&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873423	485229160							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326858	CNC(=O)c1ccc(cc1)-c1cnc([nH]1)[C@@H]1C[C@@H](O)CN1C(=O)C(C(C)C)c1cc(OC)no1 |r,w:23.26|	InChI=1S/C24H29N5O5/c1-13(2)21(19-10-20(33-4)28-34-19)24(32)29-12-16(30)9-18(29)22-26-11-17(27-22)14-5-7-15(8-6-14)23(31)25-3/h5-8,10-11,13,16,18,21,30H,9,12H2,1-4H3,(H,25,31)(H,26,27)	FBKXEIZVSGILFD-UHFFFAOYSA-N	622019	US20230312542, Example 97	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622019	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622019&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873410	485229161							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326859	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nccn1Cc1ccnc(c1)-c1ccc(cc1)C(F)(F)F |r,w:7.8|	InChI=1S/C29H30F3N5O4/c1-17(2)26(24-14-25(40-3)35-41-24)28(39)37-16-21(38)13-23(37)27-34-10-11-36(27)15-18-8-9-33-22(12-18)19-4-6-20(7-5-19)29(30,31)32/h4-12,14,17,21,23,26,38H,13,15-16H2,1-3H3	VITQYSMFYAGIMR-UHFFFAOYSA-N	622020	US20230312542, Example 102	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622020	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622020&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873267	485229162							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326860	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(C1)Oc1ccccc1 |r,w:7.8,29.34|	InChI=1S/C27H33N5O6/c1-16(2)24(22-12-23(36-3)30-38-22)27(35)32-14-17(33)11-21(32)25-28-13-20(29-25)26(34)31-10-9-19(15-31)37-18-7-5-4-6-8-18/h4-8,12-13,16-17,19,21,24,33H,9-11,14-15H2,1-3H3,(H,28,29)	UHNKVQARRLJHJV-UHFFFAOYSA-N	622021	US20230312542, Example 107	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622021	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622021&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873378	485229163							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326861	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CC(C1)c1ccccc1 |r,w:7.8|	InChI=1S/C26H31N5O5/c1-15(2)23(21-10-22(35-3)29-36-21)26(34)31-14-18(32)9-20(31)24-27-11-19(28-24)25(33)30-12-17(13-30)16-7-5-4-6-8-16/h4-8,10-11,15,17-18,20,23,32H,9,12-14H2,1-3H3,(H,27,28)	DWVLYEMUWYKLRH-UHFFFAOYSA-N	622022	US20230312542, Example 108	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622022	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622022&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873496	485229164							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326862	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(C1)c1ccccc1 |r,w:7.8,29.34|	InChI=1S/C27H33N5O5/c1-16(2)24(22-12-23(36-3)30-37-22)27(35)32-15-19(33)11-21(32)25-28-13-20(29-25)26(34)31-10-9-18(14-31)17-7-5-4-6-8-17/h4-8,12-13,16,18-19,21,24,33H,9-11,14-15H2,1-3H3,(H,28,29)	WJNAJYHCXUNFEN-UHFFFAOYSA-N	622023	US20230312542, Example 111	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622023	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622023&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873346	485229165							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326863	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc[nH]1 |r,w:7.8|	InChI=1S/C16H22N4O4/c1-9(2)14(12-7-13(23-3)19-24-12)16(22)20-8-10(21)6-11(20)15-17-4-5-18-15/h4-5,7,9-11,14,21H,6,8H2,1-3H3,(H,17,18)	RXXYAIKNNGKDOV-UHFFFAOYSA-N	622024	US20230312542, Example 112	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622024	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622024&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873317	485229166							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326864	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nccn1Cc1cncc(c1)-c1ccc(F)cc1 |r,w:7.8|	InChI=1S/C28H30FN5O4/c1-17(2)26(24-12-25(37-3)32-38-24)28(36)34-16-22(35)11-23(34)27-31-8-9-33(27)15-18-10-20(14-30-13-18)19-4-6-21(29)7-5-19/h4-10,12-14,17,22-23,26,35H,11,15-16H2,1-3H3	NMGBNTDVUCXBSE-UHFFFAOYSA-N	622025	US20230312542, Example 113	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622025	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622025&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873481	485229167							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326865	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(CC1)c1ccncc1 |r,w:7.8|	InChI=1S/C27H34N6O5/c1-16(2)24(22-13-23(37-3)31-38-22)27(36)33-15-19(34)12-21(33)25-29-14-20(30-25)26(35)32-10-6-18(7-11-32)17-4-8-28-9-5-17/h4-5,8-9,13-14,16,18-19,21,24,34H,6-7,10-12,15H2,1-3H3,(H,29,30)	ZFHYOUKJWBZVKL-UHFFFAOYSA-N	622026	US20230312542, Example 139	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622026	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622026&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873391	485229168							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326866	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCN(CC1)c1ccccc1 |r,w:7.8|	InChI=1S/C27H34N6O5/c1-17(2)24(22-14-23(37-3)30-38-22)27(36)33-16-19(34)13-21(33)25-28-15-20(29-25)26(35)32-11-9-31(10-12-32)18-7-5-4-6-8-18/h4-8,14-15,17,19,21,24,34H,9-13,16H2,1-3H3,(H,28,29)	YMVUQLBRSIEIPG-UHFFFAOYSA-N	622027	US20230312542, Example 140	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622027	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622027&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873246	485229169							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326867	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(CC1)OCc1ccccc1 |r,w:7.8|	InChI=1S/C29H37N5O6/c1-18(2)26(24-14-25(38-3)32-40-24)29(37)34-16-20(35)13-23(34)27-30-15-22(31-27)28(36)33-11-9-21(10-12-33)39-17-19-7-5-4-6-8-19/h4-8,14-15,18,20-21,23,26,35H,9-13,16-17H2,1-3H3,(H,30,31)	ORIZQMGPUFNBBT-UHFFFAOYSA-N	622028	US20230312542, Example 141	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622028	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622028&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873432	485229170							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326868	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(CC1)c1ccc(C)cn1 |r,w:7.8|	InChI=1S/C28H36N6O5/c1-16(2)25(23-12-24(38-4)32-39-23)28(37)34-15-19(35)11-22(34)26-30-14-21(31-26)27(36)33-9-7-18(8-10-33)20-6-5-17(3)13-29-20/h5-6,12-14,16,18-19,22,25,35H,7-11,15H2,1-4H3,(H,30,31)	PFWQPQBISOYUHO-UHFFFAOYSA-N	622029	US20230312542, Example 144	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622029	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622029&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873244	485229171							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326869	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(C)cs1 |r,w:7.8|	InChI=1S/C17H23N3O4S/c1-9(2)15(13-6-14(23-4)19-24-13)17(22)20-7-11(21)5-12(20)16-18-10(3)8-25-16/h6,8-9,11-12,15,21H,5,7H2,1-4H3	KDRRPFRACAOPBC-UHFFFAOYSA-N	622030	US20230312542, Example 147	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622030	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622030&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873368	485229172							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326870	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCCC(C1)C(=O)Nc1ccccc1 |r,w:7.8,30.35|	InChI=1S/C29H36N6O6/c1-17(2)25(23-13-24(40-3)33-41-23)29(39)35-16-20(36)12-22(35)26-30-14-21(32-26)28(38)34-11-7-8-18(15-34)27(37)31-19-9-5-4-6-10-19/h4-6,9-10,13-14,17-18,20,22,25,36H,7-8,11-12,15-16H2,1-3H3,(H,30,32)(H,31,37)	STECQCUHYTUUMQ-UHFFFAOYSA-N	622031	US20230312542, Example 148	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622031	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622031&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873494	485229173							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326871	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N1CCC(CC1)Nc1ccccc1 |r,w:7.8|	InChI=1S/C28H36N6O5/c1-17(2)25(23-14-24(38-3)32-39-23)28(37)34-16-20(35)13-22(34)26-29-15-21(31-26)27(36)33-11-9-19(10-12-33)30-18-7-5-4-6-8-18/h4-8,14-15,17,19-20,22,25,30,35H,9-13,16H2,1-3H3,(H,29,31)	JJHKPQUDUOZKKP-UHFFFAOYSA-N	622032	US20230312542, Example 150	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622032	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622032&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873365	485229174							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326872	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(C)Cc1ccc(cc1)-c1ccnc(C)c1 |r,w:7.8|	InChI=1S/C31H36N6O5/c1-18(2)28(26-14-27(41-5)35-42-26)31(40)37-17-23(38)13-25(37)29-33-15-24(34-29)30(39)36(4)16-20-6-8-21(9-7-20)22-10-11-32-19(3)12-22/h6-12,14-15,18,23,25,28,38H,13,16-17H2,1-5H3,(H,33,34)	RBDFOFGIPCPCLM-UHFFFAOYSA-N	622033	US20230312542, Example 153	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622033	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622033&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873376	485229175							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326873	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(C)Cc1ccc(cc1)-c1ccc(C)nc1 |r,w:7.8|	InChI=1S/C31H36N6O5/c1-18(2)28(26-13-27(41-5)35-42-26)31(40)37-17-23(38)12-25(37)29-33-15-24(34-29)30(39)36(4)16-20-7-10-21(11-8-20)22-9-6-19(3)32-14-22/h6-11,13-15,18,23,25,28,38H,12,16-17H2,1-5H3,(H,33,34)	VDGASGGTLVYSKD-UHFFFAOYSA-N	622034	US20230312542, Example 154	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622034	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622034&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873450	485229176							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326874	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(C)CC1CCN(Cc2ccccc2F)CC1 |r,w:7.8|	InChI=1S/C31H41FN6O5/c1-19(2)28(26-14-27(42-4)35-43-26)31(41)38-18-22(39)13-25(38)29-33-15-24(34-29)30(40)36(3)16-20-9-11-37(12-10-20)17-21-7-5-6-8-23(21)32/h5-8,14-15,19-20,22,25,28,39H,9-13,16-18H2,1-4H3,(H,33,34)	VQQLIAAZYKFPII-UHFFFAOYSA-N	622035	US20230312542, Example 155	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 5500						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622035	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622035&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873498	485229177							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326875	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(C)CCNc1ccccc1 |r,w:7.8|	InChI=1S/C26H34N6O5/c1-16(2)23(21-13-22(36-4)30-37-21)26(35)32-15-18(33)12-20(32)24-28-14-19(29-24)25(34)31(3)11-10-27-17-8-6-5-7-9-17/h5-9,13-14,16,18,20,23,27,33H,10-12,15H2,1-4H3,(H,28,29)	FOXWVHVNFBOTSY-UHFFFAOYSA-N	622036	US20230312542, Example 158	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622036	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622036&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873268	485229178							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326876	COc1cc(on1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1nc(c[nH]1)C(=O)N(C)[C@H](C)C(=O)NCc1ccccc1 |r,w:7.8|	InChI=1S/C28H36N6O6/c1-16(2)24(22-12-23(39-5)32-40-22)28(38)34-15-19(35)11-21(34)25-29-14-20(31-25)27(37)33(4)17(3)26(36)30-13-18-9-7-6-8-10-18/h6-10,12,14,16-17,19,21,24,35H,11,13,15H2,1-5H3,(H,29,31)(H,30,36)	GBSCPFIQKLIOOX-UHFFFAOYSA-N	622037	US20230312542, Example 159	von Hippel-Lindau disease tumor suppressor	Homo sapiens			<1000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622037	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622037&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873250	485229179							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326877	CC(C)C(C(=O)N1C[C@H](O)C[C@H]1c1ncc[nH]1)n1cc(cn1)-c1cc(C)no1 |r,w:1.2|	InChI=1S/C19H24N6O3/c1-11(2)17(25-9-13(8-22-25)16-6-12(3)23-28-16)19(27)24-10-14(26)7-15(24)18-20-4-5-21-18/h4-6,8-9,11,14-15,17,26H,7,10H2,1-3H3,(H,20,21)	PGQWCKHGSZZHSD-UHFFFAOYSA-N	622038	US20230312542, Example 160	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622038	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622038&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873278	485229180							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326878	CCCc1nc(no1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc[nH]1 |r,w:9.9|	InChI=1S/C17H25N5O3/c1-4-5-13-20-16(21-25-13)14(10(2)3)17(24)22-9-11(23)8-12(22)15-18-6-7-19-15/h6-7,10-12,14,23H,4-5,8-9H2,1-3H3,(H,18,19)	RPCAUYHTBIQUOA-UHFFFAOYSA-N	622039	US20230312542, Example 161	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622039	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622039&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873449	485229181							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
1326879	CCCc1nnc(o1)C(C(C)C)C(=O)N1C[C@H](O)C[C@H]1c1ncc[nH]1 |r,w:9.9|	InChI=1S/C17H25N5O3/c1-4-5-13-20-21-16(25-13)14(10(2)3)17(24)22-9-11(23)8-12(22)15-18-6-7-19-15/h6-7,10-12,14,23H,4-5,8-9H2,1-3H3,(H,18,19)	XIJQEVCNRXENLK-UHFFFAOYSA-N	622040	US20230312542, Example 162	von Hippel-Lindau disease tumor suppressor	Homo sapiens			 30000						US Patent		10.7270/Q25H7MF8		aid1919806	US20230312542	YAMAKOSHI, S; ISHIZAWA, K; HAGIHARA, S; SAKATA, K; NIWA, Y; TANAKA, M	10/5/2023	11/13/2023	Mitsubishi Tanabe Pharma	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=622040	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7505&target=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=622040&enzyme=von+Hippel-Lindau+disease+tumor+suppressor&column=ki&startPg=0&Increment=50&submit=Search			156873349	485229182							1	MPRRAENWDEAEVGAEEAGVEEYGPEEDGGEESGAEESGPEESGPEELGAEEEMEAGRPRPVLRSVNSREPSQVIFCNRSPRVVLPVWLNFDGEPQPYPTLPPGTGRRIHSYRGHLWLFRDAGTHDGLLVNQTELFVPSLNVDGQPIFANITLPVYTLKERCLQVVRSLVKPENYRRLDIVRSLYEDLEDHPNVQKDLERLTQERIAHQRMGD	4WQO,8QVU,8QU8,9HYN,9GIO,8RX0,8RWZ,8R5H,8C13,6R7F,6I7R,6I7Q,6GFX,5N4W,1VCB,1LM8,9MR9,9DTY,9DTX,9D4B,8VLB,8VL9,8EWV,8YMB,7KHH,7CJB,8WDK,7PI4,6ZHC,6FMK,6FMJ,6FMI,6HR2,6R6H,9N88,9T32,1HV2	von Hippel-Lindau disease tumor suppressor	VHL_HUMAN	P40337	B2RE45 Q13599 Q6PDA9